Financial Reports Latest Updates Industry Maps Economic Calendar

AGENUS INC (AGEN) Annual Reports

Q: Where can I read AGENUS INC (AGEN) annual reports?

Every year on this page links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser. 3 filings are currently indexed.

Q: What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer; a 20-F is filed by foreign private issuers (Taiwanese companies with US ADRs, such as TSMC, file 20-F). A 40-F applies to Canadian issuers under the MJDS.

AGENUS INC is listed on Nasdaq, classified by the SEC under Biological Products, (No Diagnostic Substances) (SIC 2836). This page indexes 3 annual reports, each linking to the full text on the SEC's EDGAR system.

Company profile

Exchange： Nasdaq
Fiscal year end： 12/31
SEC CIK： 1098972 →

Website：Official site ↗

Financial Highlights

FY2026 Q2 (quarterly, ended 2026-06-30)
	Current	Prior year	YoY
Revenue	$34.5M	$25.7M	+34.4%
Operating income	$11.3M	$-16.7M	+167.6%
Net income	$-567,000	$-30.0M	+98.1%
EPS (diluted)	$-0.01	$-1.00	+99.0%

Source: SEC EDGAR (XBRL company facts)

Financial history

Revenue & profit

Quarterly · In mn (USD)

Revenue 34.5 mn Net income -0.57 mn

Show table：Income statement

Item	2009Q4	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Revenue	3.33	0.81	0.62	0.99	0.67	0.79	0.65	0.64	13.4	0.63	0.87	1.09	1.11	0.81	0.74	0.39	0.72	3.07	1.56	1.62	3.95	6.38	6.85	7.64	5.96	6.59	4.45	5.58	27.0	4.21	3.36	8.35	1.64	15.9	12.8	6.45	79.9	15.7	19.9	34.5	15.1	26.9	14.8	31.3	11.7	10.7	253	20.3	25.9	20.9	22.8	28.4	22.9	25.3	24.3	83.8	28.0	23.5	25.1	26.8	24.1	25.7	30.2	34.2	33.7	34.5
Operating income	-27.7	-4.65	-4.89	-4.96	-5.02	-4.70	-4.44	-4.92	7.80	-5.77	-4.54	-4.23	-4.61	-7.33	-6.81	-6.23	-9.82	-8.22	-7.67	-17.3	-18.3	-33.2	-11.1	-18.1	-28.0	-23.6	-36.2	-19.7	-13.3	-28.9	-31.7	-30.0	-41.8	-16.6	-26.1	-39.4	26.2	-41.1	-35.9	-19.3	-27.5	-33.3	-34.8	-21.7	-41.4	-66.4	188	-54.0	-35.5	-44.6	-41.6	-57.8	-54.3	-54.7	-46.3	-4.20	-32.9	-30.2	-31.5	-25.9	-13.3	-16.7	-4.54	14.4	15.1	11.3
Net income	-30.3	-4.97	-5.71	-2.42	-5.96	-5.76	-5.53	-6.02	6.77	-6.92	-5.73	-5.44	-5.84	-11.1	-7.32	-5.78	-0.36	-7.76	-8.11	-26.0	-18.7	-40.4	-13.1	-15.6	-31.8	-28.3	-40.8	-26.1	-17.1	-31.7	-36.8	-35.0	-54.3	-25.2	-33.7	-48.9	17.4	-51.9	-46.3	-30.9	-45.3	-48.2	-51.6	-37.7	-54.4	-84.0	177	-67.6	-50.6	-49.2	-56.7	-74.1	-70.9	-73.4	-64.5	-48.6	-63.5	-54.8	-67.2	-46.8	-26.4	-30.0	63.9	-10.6	39.2	-0.57

Balance sheet

Quarterly · In mn (USD)

Total assets 173 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2009Q4	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Current assets	—	—	—	20.9	—	13.3	16.0	12.0	25.9	26.5	25.8	22.6	18.4	14.4	30.9	28.2	75.3	67.0	55.2	42.7	85.2	146	209	184	162	136	110	91.3	138	111	84.3	73.5	65.2	67.7	67.6	74.8	179	139	107	86.5	103	105	125	114	136	92.8	308	332	290	289	251	213	206	171	126	112	60.4	100	50.1	45.6	23.1	13.3	134	133	95.3	78.8
Total assets	—	—	—	30.9	—	22.2	24.4	19.8	33.2	33.3	32.2	29.1	25.1	21.4	37.7	34.8	108	100	87.6	74.5	117	180	243	242	221	196	175	157	203	176	149	138	131	132	130	136	246	207	175	155	180	186	204	215	235	192	438	466	441	456	429	414	413	384	335	314	257	292	238	226	200	185	234	227	186	173
Current liabilities	—	—	—	5.42	—	4.81	5.87	4.75	5.51	4.59	4.83	4.81	5.78	7.18	9.65	10.3	14.4	18.6	15.6	9.23	21.0	25.3	28.3	28.9	31.3	33.1	34.9	40.9	36.4	32.9	54.4	56.4	30.2	51.3	58.2	68.1	106	122	133	122	127	142	147	130	138	169	150	157	163	160	173	189	191	204	198	256	256	271	271	221	208	235	287	323	249	232
Equity	-17.0	—	—	-14.7	—	-17.1	-16.1	-20.8	-10.6	-11.4	-13.2	-17.6	-22.7	-17.3	-2.88	-4.48	63.3	57.6	48.9	23.0	46.3	87.2	77.0	70.7	44.5	16.9	-21.0	-39.1	8.90	-17.5	-51.6	-75.8	-113	-113	-130	-172	-116	-157	-200	-225	-196	-219	-198	-204	-190	-247	41.9	34.4	15.7	3.42	-20.4	-61.3	-58.5	-93.2	-129	-160	-201	-241	-292	-326	-342	-355	-274	-271	-221	-199

Cash flow

Quarterly · In mn (USD)

Operating -31.2 mn Investing 0.27 mn Financing 14.7 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2009Q4	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Operating	-24.2	-9.17	-4.14	-1.45	-4.64	-4.03	-3.40	-4.18	11.3	-3.35	-3.64	-3.28	-3.90	-5.66	-4.43	-5.54	-10.1	-9.50	-8.11	-10.5	3.30	-12.9	-18.0	-19.6	-21.5	18.5	23.8	16.0	-14.8	27.4	-26.2	-25.8	-40.2	-30.5	-24.6	-35.8	76.6	40.9	-27.8	-31.8	-34.5	-37.4	-31.6	-35.6	-42.7	-55.6	131	-22.9	-52.4	-43.5	-32.2	-47.3	-58.5	-60.0	-65.2	-40.4	-38.2	-38.2	-53.3	-28.6	-25.6	-20.2	-14.7	-16.6	-36.0	-31.2
Investing	2.16	-0.03	-0.03	9.99	-5.03	5.00	0	0	0	-0.07	-0.04	0	-0.38	-0.21	0.29	-0.07	0.34	-15.1	-0.31	-1.70	14.2	-16.2	-1.30	-27.9	-36.5	18.4	25.0	10.7	-5.26	-5.96	9.04	4.25	-1.49	-0.68	-0.82	-0.6	-1.50	-1.26	-0.84	-1.06	-0.64	-2.09	-0.87	-0.83	-0.2	-2.27	-27.4	-13.3	-7.53	-4.06	-15.6	-6.38	-11.5	0.52	11.6	2.82	0.23	-0.24	0.06	-0.02	0.06	0.28	0.08	0.78	69.0	0.27
Financing	17.6	7.88	-0.16	-3.17	0.53	0.41	6.11	0.2	2.57	4.28	2.97	-0.01	0.02	2.11	20.9	2.76	55.9	-0.72	-1.64	-0.73	36.1	74.8	78.5	0.21	-0.56	-4.66	0.57	2.19	62.1	1.29	0.41	16.8	33.8	22.6	28.5	43.4	30.1	-0.08	0.03	1.27	65.6	26.3	67.3	24.6	63.0	11.8	78.9	71.6	16.0	27.8	28.2	23.8	56.3	38.3	18.0	7.32	14.8	79.1	4.56	24.4	3.59	10.9	6.68	15.4	-0.99	14.7
Cash at period end	20.1	18.8	14.4	19.8	10.6	12.0	14.7	10.8	24.6	25.5	24.8	21.5	17.2	13.4	30.2	27.4	73.5	48.3	38.4	25.7	79.3	125	184	137	78.3	73.4	75.4	71.5	114	81.8	65.1	60.2	52.4	43.2	46.2	53.0	158	122	93.3	61.8	92.3	79.2	114	99.9	119	73.5	257	292	248	228	208	179	165	143	106	76.1	52.9	93.7	44.8	40.4	18.5	9.53	3.46	3.00	35.0	18.7

Profitability

Quarterly · %

Operating margin 32.7% Net margin -1.6%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2009Q4	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Operating margin	-830.1%	-577.4%	-782.6%	-498.8%	-747.5%	-597.8%	-679.4%	-764.3%	58.3%	-920.8%	-522.7%	-387.9%	-415.5%	-907.6%	-925.9%	-1584.7%	-1362.8%	-267.4%	-490.7%	-1070.1%	-462.7%	-520.6%	-161.6%	-237.6%	-469.4%	-358.1%	-814.7%	-352.9%	-49.2%	-686.6%	-942.5%	-359.0%	-2551.9%	-104.3%	-203.7%	-611.1%	32.8%	-261.8%	-180.2%	-55.9%	-181.5%	-123.5%	-234.6%	-69.4%	-353.0%	-618.8%	74.1%	-266.7%	-136.7%	-213.0%	-182.9%	-203.5%	-237.3%	-216.1%	-190.6%	-5.0%	-117.4%	-128.4%	-125.5%	-96.5%	-55.3%	-65.0%	-15.0%	42.1%	44.6%	32.7%
Net margin	-909.2%	-617.5%	-914.0%	-243.2%	-887.6%	-732.1%	-846.6%	-934.8%	50.6%	-1104.5%	-659.5%	-499.2%	-526.0%	-1380.0%	-994.4%	-1470.0%	-49.6%	-252.5%	-518.7%	-1604.6%	-474.1%	-633.7%	-191.6%	-204.3%	-533.3%	-429.6%	-917.0%	-468.5%	-63.5%	-753.7%	-1096.7%	-419.4%	-3316.7%	-158.6%	-263.5%	-757.2%	21.8%	-330.1%	-232.1%	-89.4%	-299.3%	-179.1%	-348.2%	-120.7%	-464.2%	-782.8%	70.1%	-333.7%	-195.1%	-235.3%	-249.1%	-261.1%	-309.6%	-290.3%	-265.4%	-58.0%	-226.6%	-233.1%	-267.7%	-174.4%	-109.6%	-116.8%	211.4%	-31.0%	116.2%	-1.6%

Returns & leverage

Quarterly · %

ROE -2088.2% ROA 51.4%

ROE / ROA = trailing four-quarter net income ÷ average equity / total assets (annual mode: the year’s net income ÷ average of opening and closing). Not computed when the denominator is zero or negative.

Show table：Returns & leverage

Item	2009Q4	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
ROE	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-121.2%	-105.1%	-95.7%	-455.4%	-110.6%	-128.8%	-156.2%	-187.5%	-222.5%	-170.7%	-416.5%	-803.7%	-421.0%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-2088.2%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
ROA	—	—	—	-140.5%	—	-89.3%	-80.7%	-91.8%	-31.8%	-42.2%	-42.1%	-46.3%	-82.0%	-103.0%	-85.1%	-94.1%	-36.9%	-34.9%	-35.1%	-77.2%	-53.7%	-66.5%	-59.5%	-55.5%	-59.6%	-47.2%	-55.8%	-63.6%	-52.9%	-62.0%	-69.0%	-81.7%	-94.5%	-98.1%	-106.0%	-117.9%	-48.0%	-69.1%	-84.9%	-76.5%	-81.8%	-87.0%	-92.8%	-98.9%	-92.5%	-120.5%	0.4%	-8.4%	-7.4%	3.0%	-51.7%	-52.5%	-58.8%	-65.5%	-74.0%	-70.8%	-74.7%	-68.5%	-81.6%	-86.0%	-85.5%	-71.3%	-16.6%	-1.4%	32.3%	51.4%

EPS

Quarterly · US$

EPS US$-0.01

Show table：EPS

Item	2009Q4	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
EPS（US$）	—	—	—	—	-0.33	—	—	—	0.29	-0.31	-0.24	-0.23	-0.35	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-0.53	—	—	—	0.12	-0.38	-0.33	-0.22	-0.31	—	-0.28	-0.18	—	-0.37	0.72	-0.29	-0.19	-0.17	-0.19	-0.24	-0.22	-0.20	-0.16	-0.12	-3.04	-2.52	-3.08	-1.94	-1.03	-1.00	1.94	-0.37	1.02	-0.01

Revenue & profit

Year-to-date · In mn (USD)

Revenue 68.3 mn Net income 38.6 mn

Year-to-date = summed from the first quarter of the fiscal year; balance-sheet items are period-end balances.

Balance sheet

Year-to-date · In mn (USD)

Total assets 173 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Cash flow

Year-to-date · In mn (USD)

Operating -67.2 mn Investing 69.2 mn Financing 13.7 mn

Positive = cash in, negative = cash out.

Profitability

Year-to-date · %

Operating margin 38.6% Net margin 56.6%

Gross, operating and net margin = the respective profit ÷ revenue.

Returns & leverage

Year-to-date · %

ROE -2088.2% ROA 51.4%

EPS

Year-to-date · US$

EPS US$1.01

Revenue & profit

Annual · In mn (USD)

Revenue 114 mn Net income -3.08 mn

Annual = sum of four quarters of a complete fiscal year (incomplete years are omitted); balance-sheet items are year-end balances.

Show table：Income statement

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	2.76	16.0	3.05	6.98	24.8	22.6	42.9	36.8	150	88.2	296	98.0	156	103	114
Operating income	-19.1	-6.74	-25.0	-43.0	-80.7	-107	-104	-124	-70.1	-117	25.8	-179	-160	-120	-20.2
Net income	-23.3	-11.3	-30.1	-42.2	-87.9	-127	-121	-162	-112	-183	-28.7	-231	-257	-232	-3.08

Balance sheet

Annual · In mn (USD)

Total assets 227 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Current assets	12.0	22.6	28.2	42.7	184	91.3	73.5	74.8	86.5	114	332	213	112	45.6	133
Total assets	19.8	29.1	34.8	74.5	242	157	138	136	155	215	466	414	314	226	227
Current liabilities	4.75	4.81	10.3	9.23	28.9	40.9	56.4	68.1	122	130	157	189	256	221	323
Equity	-20.8	-17.6	-4.48	23.0	70.7	-39.1	-75.8	-172	-225	-204	34.4	-61.3	-160	-326	-271

Cash flow

Annual · In mn (USD)

Operating -77.2 mn Investing 1.19 mn Financing 36.6 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Operating	-16.3	1.01	-19.5	-38.2	-47.2	36.8	-39.4	-131	57.9	-139	10.2	-175	-224	-158	-77.2
Investing	-0.03	-0.1	-0.36	-16.8	-31.2	17.6	2.06	-3.59	-4.66	-4.44	-43.1	-33.6	3.40	0.03	1.19
Financing	7.24	9.81	25.8	52.8	190	-2.46	80.5	128	31.3	184	225	95.8	120	123	36.6
Cash at period end	10.8	21.5	27.4	25.7	137	71.5	60.2	53.0	61.8	99.9	292	179	76.1	40.4	3.00

Profitability

Annual · %

Operating margin -17.7% Net margin -2.7%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Operating margin	-692.6%	-42.2%	-820.2%	-616.9%	-325.2%	-476.1%	-242.1%	-336.6%	-46.7%	-133.0%	8.7%	-183.0%	-102.1%	-116.4%	-17.7%
Net margin	-844.5%	-71.0%	-987.4%	-604.9%	-354.1%	-562.6%	-281.5%	-440.5%	-74.3%	-207.4%	-9.7%	-235.3%	-164.7%	-224.5%	-2.7%

Returns & leverage

Annual · %

ROE -803.7% ROA -1.4%

Show table：Returns & leverage

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
ROE	—	—	—	-455.4%	-187.5%	-803.7%	—	—	—	—	—	—	—	—	—
ROA	-117.5%	-46.3%	-94.1%	-77.2%	-55.5%	-63.6%	-81.7%	-117.9%	-76.5%	-98.9%	-8.4%	-52.5%	-70.8%	-86.0%	-1.4%

EPS

Annual · US$

EPS US$-0.46

Show table：EPS

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
EPS（US$）	—	-0.49	—	—	—	—	—	—	-0.81	—	—	-0.79	-0.70	-10.58	-0.46

Source: SEC EDGAR (XBRL company facts)

Annual reports by year

	10-K
2025	Open full text →
2024	Open full text →
2023	Open full text →

10-K: annual report of a US domestic issuer. Filings are the original documents hosted on SEC EDGAR — this site neither mirrors nor edits them.

FAQ

Where can I read AGENUS INC (AGEN) annual reports?

Every year in the table above links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser without downloading anything. 3 filings are currently indexed.

What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer, with sections fixed by law: Item 1 Business, Item 1A Risk Factors, Item 7 Management's Discussion and Analysis. A 20-F is filed by foreign private issuers — Taiwanese companies with US ADRs, such as TSMC, file 20-F rather than 10-K. A 40-F applies to Canadian issuers under the MJDS.

Are earnings call materials available here?

No. Earnings calls are not SEC filings, so US pages on this site cover annual reports only. Taiwan has a mandatory investor-conference disclosure regime, and those materials are indexed under Annual Reports.

Source: US Securities and Exchange Commission (SEC) EDGAR. This site indexes public filings and links to them; it hosts no copies, offers no investment advice, and makes no warranty as to timeliness or completeness.
Back to US annual reports, or see the supply-chain maps.